Stocks · Healthcare · Medical - Instruments & Supplies
Solventum Corporation SOLV
$87.85 +0.09% Close, Oct 2, 2026 · NYSE · Market cap $15.21B
Inexpensive vs sectorLow risk
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $8.19, up 277.4% year over year.
- Operating margin widened to 25.0% from 9.3% a year earlier.
- Earnings beat analyst estimates in each of the last 10 quarters (average surprise over the last four: +13.4%).
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 28%
- EPS growth (TTM, YoY)Top 6%
- FCF growth (TTM, YoY)Bottom 7%
- Revenue growth, 3-year CAGRBottom 26%
- Revenue growth accelerationBottom 48%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 7%
- Gross marginBottom 39%
- Operating marginTop 10%
- Cash conversion (OCF / net income)Bottom 9%
- Accruals (lower is better)Bottom 8%
- Net debt / EBITDA (lower is better)Bottom 40%
- Interest coverTop 19%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 3%
- Free-cash-flow yieldTop 38%
- EBITDA / enterprise valueTop 6%
- Sales / enterprise valueTop 31%
- P/E vs own 5-year history (lower is better)Bottom 49%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 46%
- 6-month returnTop 25%
- 1-year return vs S&P 500Top 44%
- Distance from 52-week highTop 9%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 33%
- Consecutive EPS beatsTop 6%
- Share of analysts rating BuyBottom 47%
- Upside to consensus price targetBottom 13%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 8%
- Maximum drawdown, 3 yearsTop 13%
- Beta vs S&P 500 (lower is better)Top 30%
- Net debt / EBITDA (lower is better)Bottom 40%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -0.6% | -0.9% | ↓ |
| EPS growth (YoY) | 276.5% | 277.4% | ↑ |
| Gross margin | 54.5% | 54.7% | ↑ |
| Operating margin | 9.3% | 25.0% | ↑ |
| FCF margin | 1.8% | -1.4% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -0.9% | -0.6% | ↓ | Bottom 28% |
| EPS growth (TTM, YoY) | 277.4% | 276.5% | ↑ | Top 6% |
| Gross margin | 54.7% | 54.5% | ↑ | Bottom 39% |
| Operating margin | 25.0% | 9.3% | ↑ | Top 10% |
| Net margin | 17.3% | 4.5% | ↑ | — |
| Free-cash-flow margin | -1.4% | 1.8% | ↓ | — |
| Return on invested capital | 15.9% | — | Top 7% | |
| Revenue growth, 3-year CAGR | 0.8% | — | Bottom 26% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 0.15×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 8.6%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 2.0%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +15.0 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 1.88×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 7.8×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 2.33%
- Shareholder yield
- 2.33%
- Share count change, 1 year
- -0.5%
- Share count change, 3-year CAGR
- +0.3%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 5, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 10
- Beats in the last 8 reports
- 8 of 8
- Average EPS surprise, last 4
- +13.4%
- Average 2-day reaction, last 8
- +0.5%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $91.22
- Target vs current price
- +3.8%
- Analysts with a rating
- 12
- Share rating Buy or Strong Buy
- 75%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 5, 2026 | +34.2% | -0.5% | -4.4% | +3.4% | — |
| May 5, 2026 | +9.6% | +2.4% | +9.9% | +13.3% | +28.7% |
| Feb 26, 2026 | +4.7% | +2.5% | -6.2% | -13.9% | +2.2% |
| Nov 6, 2025 | +4.9% | -2.1% | +9.1% | +26.0% | +11.9% |
| Aug 7, 2025 | +16.6% | -0.9% | +2.5% | -0.3% | -4.5% |
| May 8, 2025 | +10.7% | +1.7% | +8.6% | +15.1% | +11.8% |
| Feb 27, 2025 | +7.6% | -0.7% | -7.4% | -11.7% | -13.5% |
| Nov 7, 2024 | +18.0% | +1.3% | -5.5% | -6.2% | +0.9% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | $2.55 | $1.90 | +34.2% | $2.21B |
| May 5, 2026 | $1.48 | $1.35 | +9.6% | $2.01B |
| Feb 26, 2026 | $1.57 | $1.50 | +4.7% | $2.00B |
| Nov 6, 2025 | $1.50 | $1.43 | +4.9% | $2.10B |
| Aug 7, 2025 | $1.69 | $1.45 | +16.6% | $2.16B |
| May 8, 2025 | $1.34 | $1.21 | +10.7% | $2.07B |
| Feb 27, 2025 | $1.41 | $1.31 | +7.6% | $2.07B |
| Nov 7, 2024 | $1.64 | $1.39 | +18.0% | $2.08B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 10.7× | 17.4× | 47th | Top 3% |
| P/E (forward) | 12.3× | — | — | — |
| EV / EBITDA | 7.7× | — | — | Top 6% |
| EV / Sales | 2.42× | — | — | Top 31% |
| Free-cash-flow yield | -0.78% | — | — | Top 38% |
| Earnings yield | 9.32% | — | — | Top 3% |
P/E over the past five years
Range 7.6× – 33.8× since Dec 31, 2022. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +20.3%
- Earnings per share growth (TTM)
- +277.4%
- Change in P/E multiple
- -68.4%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 71
- 50-day average slope (20 days)
- +5.2%
- 200-day average slope (20 days)
- +0.8%
- Distance from 50-day average
- -0.3%
- Distance from 200-day average
- +12.7%
- RSI (14)
- 46.0
- Relative volume
- 1.02×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 29.4%
- Volatility vs own 5-year history
- 42th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.78
- Correlation with S&P 500
- 0.39
- Current drawdown from 1-year high
- -5.0%
- Maximum drawdown, 3 years
- -40.0%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Mar 26, 2024 | Jul 9, 2024 | -40.0% | 71 days | 158 days (Feb 25, 2025) |
| Jan 9, 2026 | Apr 7, 2026 | -27.5% | 59 days | 77 days (Jul 28, 2026) |
| Feb 26, 2025 | Apr 8, 2025 | -25.0% | 29 days | 160 days (Nov 25, 2025) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $15.21B
- P/E (TTM)
- 10.7
- EPS, diluted (TTM)
- $8.19
- Revenue (TTM)
- $8.31B
- 52-week range
- $62.38 – $94.16
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $8.17B | $8.13B | $8.20B | $8.25B | $8.32B |
| Gross profit | $4.92B | $4.70B | $4.69B | $4.59B | $4.45B |
| Operating income | $1.88B | $1.69B | $1.69B | $1.04B | $2.18B |
| Net income | $1.46B | $1.34B | $1.35B | $479.0M | $1.56B |
| EPS (diluted) | $8.47 | $7.79 | $7.79 | $2.76 | $8.88 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.08B | $2.08B | $2.07B | $2.16B | $2.10B | $2.00B | $2.01B | $2.21B |
| Net income | $122.0M | $31.0M | $137.0M | $90.0M | $1.27B | $63.0M | $13.0M | $92.0M |
| EPS (diluted) | $0.70 | $0.18 | $0.78 | $0.51 | $7.22 | $0.37 | $0.07 | $0.53 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $2.20B | $1.68B | $1.92B | $1.19B | $369.0M |
| Capital expenditure | -$277.0M | -$251.0M | -$290.0M | -$380.0M | -$379.0M |
| Free cash flow | $1.93B | $1.43B | $1.63B | $805.0M | -$10.0M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $0 | $0 | $0 | $0 | $0 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $403.0M
- Total assets
- $14.24B
- Total liabilities
- $9.44B
- Total debt
- $5.29B
- Net debt
- $4.88B
- Shareholders’ equity
- $4.80B
As of Jun 30, 2026 (filed Aug 5, 2026).
Short interest
- Shares sold short
- 4,862,491
- Days to cover
- 5.67
- Change vs previous report
- +13.1%
FINRA short interest, settlement date Sep 15, 2026.